NUVATION BIO INC's ticker is NUVB and the CUSIP is 67080N101. A total of 128 filers reported holding NUVATION BIO INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $128,034 | +43.5% | 95,548 | +92.8% | 0.00% | – |
Q2 2023 | $89,224 | +96.7% | 49,569 | +80.3% | 0.00% | – |
Q1 2023 | $45,368 | +0.2% | 27,496 | +16.6% | 0.00% | – |
Q4 2022 | $45,291 | +29.4% | 23,589 | +49.6% | 0.00% | – |
Q3 2022 | $35,000 | -10.3% | 15,764 | +30.3% | 0.00% | – |
Q2 2022 | $39,000 | – | 12,095 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 15,072,340 | $28,938,893 | 9.75% |
Aisling Capital Management LP | 2,541,009 | $4,878,737 | 3.22% |
EDBI Pte Ltd | 1,270,504 | $2,439,368 | 3.11% |
EcoR1 Capital, LLC | 13,896,543 | $26,681,363 | 0.81% |
Deep Track Capital, LP | 8,221,188 | $15,784,681 | 0.66% |
AlphaCentric Advisors LLC | 325,000 | $624,000 | 0.62% |
683 Capital Management, LLC | 2,500,000 | $4,799,999 | 0.41% |
BRAIDWELL LP | 4,122,900 | $7,915,968 | 0.26% |
Abrams Capital Management | 3,811,513 | $7,318,105 | 0.26% |
Redmile Group, LLC | 3,031,009 | $5,819,537 | 0.24% |